To delve deeper into the biological functions of DBT in kidney cancer, specifically in kidney renal clear cell carcinoma (KRCC), we conducted a detailed examination of DBT's mRNA and protein levels in two renal cell carcinoma (RCC) cell lines: 786-O and A498. Here, DBT is linked to hereditary clear cell renal cell carcinoma.